Study of 3,000 Patients Links Xylitol to Stroke

Elevated blood levels of the sugar substitute xylitol are associated with an increased risk of myocardial infarction, stroke, and mortality. Research involving two cohorts in Canada and the United Kingdom identified a dose-dependent relationship between xylitol concentrations and major adverse cardiovascular events.

In the Canadian cohort, participants with the highest xylitol levels faced a 57% higher risk of cardiovascular events over a six-year period. The U.K. cohort demonstrated an 18% increased risk over a 30-year follow-up. These findings remained statistically significant after adjusting for variables including hypertension, smoking, age, and diabetes.

United Kingdom

The data, presented at a recent medical congress, suggest that xylitol may increase platelet clotting activity. While the findings have not yet undergone formal peer review, they challenge the current regulatory classification of xylitol as a safe sugar alternative.

These results indicate a potential need for reevaluating the long-term cardiovascular safety profiles of common artificial sweeteners. Further clinical trials are required to establish a definitive causal link and determine the impact of reducing xylitol intake on patient health outcomes.